You are here

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
494 OR502, a best-in-class anti-LILRB2 antibody that enhances both innate and adaptive anti-tumor immune responses

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023234023
Dec 20236309
Jan 202422011
Feb 20245405
Mar 202468024
Apr 20244406
May 20245608
Jun 202450010
Jul 20248007
Aug 20243205
Sep 20243002
Oct 202448015
Nov 20245807
Dec 20246608
Jan 202543010
Feb 20251607
Mar 2025207
Apr 2025005
May 2025007
Jun 2025006
Total9660182